Cardiac Disease Modeling with Engineered Heart Tissue
Handbook of Experimental Pharmacology · 2023
DOI: 10.1007/164_2023_681 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Handbook of Experimental Pharmacology, 2023. Verfasst von Lin Cai und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Science, Hubei University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Heart Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben.
Abstract (Originalsprache)
The rhythmically beating heart is the foundation of life-sustaining blood flow. There are four chambers and many different types of cell in the heart, but the twisted myofibrillar structures formed by cardiomyocytes are particularly important for cardiac contraction and electrical impulse transmission properties. The ability to generate cardiomyocytes using human-induced pluripotent stem cells has essentially solved the cell supply shortage for in vitro simulation of cardiac tissue function; however, modeling heart at the tissue level needs mature myocardial structure, electrophysiology, and contractile characteristics. Here, the current research on human functionalized cardiac microtissue in modeling cardiac diseases is reviewed and the design criteria and practical applications of different human engineered heart tissues, including cardiac organoids, cardiac thin films, and cardiac microbundles are analyzed. Table summarizing the ability of several in vitro myocardial models to assess heart structure and function for cardiac disease modeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Science, Hubei University, Wuhan, Hubei, China.
- State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Science, Hubei University, Wuhan, Hubei, China. dongh.zhang@hubu.edu.cn.
Zitieren
APA
Cai, L., Wang, R., & Zhang, D. (2023). Cardiac Disease Modeling with Engineered Heart Tissue. Handbook of Experimental Pharmacology. https://doi.org/10.1007/164_2023_681
Vancouver
Cai L, Wang R, Zhang D. Cardiac Disease Modeling with Engineered Heart Tissue. Handbook of Experimental Pharmacology. 2023. doi:10.1007/164_2023_681
BibTeX
@article{Cai2023,
author = {Cai, Lin and Wang, Ruxiang and Zhang, Donghui},
title = {Cardiac Disease Modeling with Engineered Heart Tissue},
journal = {Handbook of Experimental Pharmacology},
year = {2023},
doi = {10.1007/164_2023_681}
}
EUVIMED